News

Announcements

NuvoNuro Receives HEAL grant

Research

Chemist’s Innovation Spurs Drugs that Hang on Through Thick and Thin

The newly launched Hyku Biosciences provides a platform for covalent drug development which may be a better approach for treating diseases like cancer.

Using SuTex, short for sulfur-triazole exchange chemistry, Ken Hsu has created an approach to target sites on proteins that have extra electrons to share. This covalent bond is very stable compared with bonds formed by traditional drugs. Credit: Zhihong Li

Accolades

Emmie Stumbo Receives Safety Fellowship

Accolades

Chemistry Graduate Student Awards Showcase 2023

Announcements

Ken Hsu Founder of New Biotech Company